Table 1

Demographic and clinicopathologic parameters of patients from different cohorts

ParametersHong Kong cohort (n=96)Shanghai cohort (n=116)
Patients with HCCHealthy controlsHepatitis B carriersPatients with HCC
Age (years)
α-fetoprotein (ng/ml)
Alanine aminotransferase (U/l)
Aspartate aminotransferase (U/l)#
Hepatitis B surface antigen
Pathological tumour-node-metastasis stage*
 Early (I, II)4145
 Late (III, IV)5511
Tumour size (cm)*
  • * Data indicated in the cohort from Shanghai are based on 56 cases.

  • Data indicated in the cohorts from Hong Kong and Shanghai are based on 94 and 56 cases, respectively.

  • HCC, hepatocellular carcinoma.

  • # Data indicated in the Shanghai cohort are based on 25 hepatitis B carriers.